Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Market Analysis & Valuation

UpdatedJun 05, 2025
DataAggregated Company Financials
Companies210
  • 7D0.9%
  • 3M-3.8%
  • 1Y2.0%
  • YTD5.9%

The market has been flat over the last week. In line with that, the market has also been flat over the past year. As for the next few years, earnings are expected to grow by 11% per annum.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Swiss Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 05 Jun 2025CHF 1.8tCHF 784.6bCHF 106.3b20.3x17.3x2.3x
Sat, 03 May 2025CHF 1.8tCHF 837.2bCHF 158.4b19.6x11.4x2.2x
Mon, 31 Mar 2025CHF 1.9tCHF 849.9bCHF 158.9b20x11.8x2.2x
Wed, 26 Feb 2025CHF 1.9tCHF 810.7bCHF 117.1b21.2x16.4x2.4x
Fri, 24 Jan 2025CHF 1.8tCHF 817.9bCHF 117.8b21.3x15.6x2.2x
Sun, 22 Dec 2024CHF 1.7tCHF 812.8bCHF 117.3b20.6x14.6x2.1x
Tue, 19 Nov 2024CHF 1.7tCHF 811.6bCHF 117.2b19.6x14.8x2.1x
Thu, 17 Oct 2024CHF 1.8tCHF 806.1bCHF 114.3b21.2x15.9x2.3x
Sat, 14 Sep 2024CHF 1.8tCHF 802.4bCHF 113.9b21x15.8x2.2x
Mon, 12 Aug 2024CHF 1.8tCHF 802.4bCHF 136.5b20.9x13.1x2.2x
Wed, 10 Jul 2024CHF 1.8tCHF 801.8bCHF 125.7b21.3x14.4x2.3x
Fri, 07 Jun 2024CHF 1.8tCHF 799.4bCHF 125.3b22.3x14.6x2.3x
Sun, 05 May 2024CHF 1.7tCHF 797.7bCHF 125.2b21.4x13.7x2.1x
Tue, 02 Apr 2024CHF 1.8tCHF 766.5bCHF 96.9b21.9x18.4x2.3x
Thu, 29 Feb 2024CHF 1.7tCHF 788.5bCHF 111.1b19.8x15.5x2.2x
Sat, 27 Jan 2024CHF 1.7tCHF 765.2bCHF 109.7b17.9x15.6x2.2x
Mon, 25 Dec 2023CHF 1.7tCHF 763.3bCHF 109.8b18.4x15.3x2.2x
Wed, 22 Nov 2023CHF 1.6tCHF 771.9bCHF 111.4b17.9x14.6x2.1x
Fri, 20 Oct 2023CHF 1.6tCHF 760.3bCHF 100.4b17.6x15.7x2.1x
Sun, 17 Sep 2023CHF 1.7tCHF 751.5bCHF 99.5b18.7x16.9x2.2x
Tue, 15 Aug 2023CHF 1.7tCHF 746.0bCHF 75.2b18.3x22.4x2.3x
Thu, 13 Jul 2023CHF 1.7tCHF 750.2bCHF 76.2b19.2x22.3x2.3x
Sat, 10 Jun 2023CHF 1.7tCHF 786.8bCHF 82.6b19x20.9x2.2x
Mon, 08 May 2023CHF 1.8tCHF 785.7bCHF 81.4b19.4x21.9x2.3x
Wed, 05 Apr 2023CHF 1.7tCHF 779.0bCHF 69.2b19.5x25x2.2x
Fri, 03 Mar 2023CHF 1.7tCHF 785.9bCHF 71.0b19.2x24.3x2.2x
Sun, 29 Jan 2023CHF 1.8tCHF 786.8bCHF 94.3b17.9x18.8x2.3x
Tue, 27 Dec 2022CHF 1.7tCHF 787.4bCHF 94.1b17.5x17.7x2.1x
Thu, 24 Nov 2022CHF 1.7tCHF 790.4bCHF 95.1b17.8x18.1x2.2x
Sat, 22 Oct 2022CHF 1.6tCHF 802.5bCHF 103.5b17x15.7x2x
Mon, 19 Sep 2022CHF 1.7tCHF 791.0bCHF 102.2b17.8x16.2x2.1x
Wed, 17 Aug 2022CHF 1.8tCHF 789.7bCHF 102.1b17.7x17.2x2.2x
Fri, 15 Jul 2022CHF 1.7tCHF 806.6bCHF 106.5b17x16x2.1x
Sun, 12 Jun 2022CHF 1.7tCHF 811.2bCHF 106.8b17.9x16.3x2.1x
Price to Earnings Ratio

16.3x


Total Market Cap: CHF 1.7tTotal Earnings: CHF 106.8bTotal Revenue: CHF 811.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Market Price to Earnings3Y Average 17.1x202320242025
Current Market PE
  • Investors are relatively neutral on the Swiss market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading close to its 3-year average PE ratio of 17.1x.
Past Earnings Growth
  • Both revenue and earnings for Swiss listed companies have remained mostly flat over the last three years.
  • This means sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.

Sector Trends

Which sectors have driven the changes within the Swiss Market?

CH Market0.89%
Healthcare2.50%
Utilities1.00%
Financials0.59%
Industrials0.55%
Telecom0.36%
Tech0.28%
Consumer Staples-0.12%
Materials-0.42%
Consumer Discretionary-0.74%
Real Estate-0.84%
Sector PE
  • Investors favour the Consumer Discretionary sector the most for future growth, which is trading above its 3-year average PE ratio of 23.9x.
    • Analysts are expecting annual earnings growth of 11.3%, which is lower than the prior year's growth of 13.1% per year.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 26% over the next 5 years.
  • This is better than its past earnings growth rate of 17% per year.
  • In contrast, the Real Estate sector is expected to see its earnings decline by 3.7% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
NOVN NovartisCHF 96.043.6%
+CHF 6.5b		1.6%PE17.9xHealthcare
ROG Roche HoldingCHF 267.202.7%
+CHF 5.6b		13.2%PE25.7xHealthcare
UBSG UBS GroupCHF 26.962.6%
+CHF 2.1b		-3.5%PE20.1xFinancials
GALD Galderma GroupCHF 112.507.2%
+CHF 1.8b		56.3%PE141.2xHealthcare
GIVN GivaudanCHF 4.22k2.7%
+CHF 1.0b		-2.4%PE35.8xMaterials
See more
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Market Insights

Header cover image

🤖 A.I. Enters the “Show Me The Money” Phase

Richard Bowman avatar
Richard Bowman
|
|

5 comments

The AI frenzy of 2023 and 2024 has cooled down and entered the "show me the money" phase. Earnings season has shed a lot of light on where we stand. So it’s time for an update on the industry and a look at the companies successfully deploying AI, monetizing it, and the potential opportunities for investors.
Continue reading
🧬 The Convergence of Genomic Medicine and AI Drug Discovery
Last Week

🧬 The Convergence of Genomic Medicine and AI Drug Discovery

Latest News

PGHN

CHF 1,086.00

Partners Group Holding

7D

-0.7%

1Y

-10.1%

NOVN

CHF 96.04

Novartis

7D

3.6%

1Y

1.6%

SDZ

CHF 42.45

Sandoz Group

7D

5.1%

1Y

35.6%

SIKA

CHF 218.70

Sika

7D

-0.8%

1Y

-19.8%

Is Now The Time To Look At Buying Sika AG (VTX:SIKA)?

Jun 02
Is Now The Time To Look At Buying Sika AG (VTX:SIKA)?

UBSG

CHF 26.96

UBS Group

7D

2.6%

1Y

-3.5%

GEBN

CHF 628.20

Geberit

7D

3.3%

1Y

13.6%

SREN

CHF 143.65

Swiss Re

7D

-1.3%

1Y

27.3%

Swiss Re AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 21
Swiss Re AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

ROG

CHF 267.20

Roche Holding

7D

2.7%

1Y

13.2%

GALD

CHF 112.50

Galderma Group

7D

7.2%

1Y

56.3%

Investors Appear Satisfied With Galderma Group AG's (VTX:GALD) Prospects As Shares Rocket 28%

May 20
Investors Appear Satisfied With Galderma Group AG's (VTX:GALD) Prospects As Shares Rocket 28%

GIVN

CHF 4,224.00

Givaudan

7D

2.7%

1Y

-2.4%

Here's Why We Think Givaudan (VTX:GIVN) Might Deserve Your Attention Today

May 20
Here's Why We Think Givaudan (VTX:GIVN) Might Deserve Your Attention Today

CFR

CHF 154.20

Compagnie Financière Richemont

7D

-1.1%

1Y

5.0%

SOON

CHF 254.30

Sonova Holding

7D

-1.3%

1Y

-12.0%

HOLN

CHF 91.64

Holcim

7D

-1.9%

1Y

15.9%

NESN

CHF 87.13

Nestlé

7D

-0.4%

1Y

-10.8%

ZURN

CHF 581.60

Zurich Insurance Group

7D

0.9%

1Y

22.5%

BCVN

CHF 93.45

Banque Cantonale Vaudoise

7D

-2.6%

1Y

-2.0%